Please login to the form below

Not currently logged in
Email:
Password:

UCLA’s Eugene Washington joins J&J board

Health policy specialist is also chair of government body to develop comparative effectiveness research programme

J&J, Eugene WashingtonJohnson & Johnson (J&J) has appointed health policy specialist Dr Eugene Washington of the University of California, Los Angeles (UCLA) to the company's board of directors.

Washington is currently vice chancellor of health sciences and dean of the David Geffen School of Medicine at UCLA, as well as chair of the board of governors of the Patient-Centered Outcomes Research Institute (PCROI).

The Institute is a national research organisation authorised by Barack Obama's Patient Protection and Affordable Care Act to develop a comparative effectiveness research programme, which can be used to inform health policy through evidence-based research.

"Gene has dedicated his life to improving healthcare as a practitioner, researcher, teacher, administrator and policy advisor,” said Bill Weldon, chair of J&J.

“He brings our board valuable leadership and insight into analysing healthcare policy, assessing medical technologies and sharing forward-looking perspectives on the role we can play in addressing the world's healthcare challenges."

Washington joined UCLA in 2010 having previously held the position of executive vice chancellor, provost and professor of gynaecology, epidemiology and health policy at the University of California San Francisco (UCSF).

The other positions he currently holds include serving as a member of the board of directors of the California Wellness Foundation.

13th November 2012

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....

Infographics